Cincinnati Enquirer: Lost sense of smell among coronavirus symptoms
UC expert in diseases of the ear, nose and throat researching link
Ear, Nose and Throat specialists across the nation are seeing an uptick in patients showing up with decreased or completely lost sense of smell in conjunction with the arrival of the conoravirus. It may be a clue in identifying individuals who are impacted by this virus.
Ahmad Sedaghat, MD, PhD, associate professor in the University of Cincinnati College of Medicine and an Ear, Nose and Throat specialist at UC Health, is performing research in this area of coronavirus-associated smell loss in close collaboration with other experts. He spoke with the Cincinnati Enquirer about this emerging area of interest associated with COVID-19.
"If you experience a decrease or complete loss of the sense of smell with no nasal obstruction – that's according to doctors coming out of Europe – the odds are incredibly high that you are infected with the novel coronavirus," Sedaghat told a reporter for the Enquirer.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Breakthrough skin science discovery
March 12, 2026
A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.